DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer-Reference-Cited by-同舟云学术

DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer

Published:2015-11-12 Issue:12 Volume:106 Page:1722-1729
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Ouchi Kota¹²,Takahashi Shin¹²,Yamada Yasuhide³,Tsuji Shingo⁴,Tatsuno Kenji⁴,Takahashi Hidekazu¹²,Takahashi Naoki³,Takahashi Masanobu¹²,Shimodaira Hideki¹²,Aburatani Hiroyuki⁴,Ishioka Chikashi¹²

Affiliation:

1. Department of Clinical Oncology Institute of Development, Aging and Cancer Tohoku University Sendai Japan

2. Department of Medical Oncology Tohoku University Hospital SendaiJapan

3. Gastrointestinal Oncology Division National Cancer Center Hospital Tokyo Japan

4. Genome Science Division Research Center for Advanced Science and Technology The University of Tokyo Tokyo Japan

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12827

Reference32 articles.

1. Global cancer statistics

2. Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

3. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

4. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

5. Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide DNA methylation status is a predictor of the efficacy of anti-EGFR antibodies in the second-line treatment of metastatic colorectal cancer: Translational research of the EPIC trial;International Journal of Colorectal Disease;2024-06-11

2. Identification of cell-specific epigenetic patterns associated with chondroitin sulfate treatment response in an endemic arthritis, Kashin-Beck disease;Bone & Joint Research;2024-05-17

3. Genome-wide DNA methylation status is a predictor of the efficacy of anti-EGFR antibodies in the second-line treatment of metastatic colorectal cancer: Translational research of the EPIC trial;2024-02-22

4. Novel DNA methylation-based epigenetic signatures in colorectal cancer from peripheral blood leukocytes;American Journal of Cancer Research;2024

5. How does understanding epigenetics help circumvent HER-2 antibody resistance?;Overcoming Cancers Resistant to HER-2 Antibodies;2024